Position in WGS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$29,477,943
New position
Shares Held
459,015
first reported quarter
Ownership
1.55%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026EVENTIDE ASSET MANAGEMENT, LLC holds $321,842,111 across 6 Diagnostics & Research names. WGS ranks #3 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
2,362,379 | $218,212,948 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
50,751 | $64,007,161 | |
| 3 | WGS |
GeneDx Holdings Corp.
This page
|
459,015 | $29,477,943 | |
| 4 | CSTL |
Castle Biosciences Inc
|
386,425 | $9,486,733 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
782 | $439,397 | |
| 6 | DGX |
Quest Diagnostics Inc
|
1,112 | $217,929 |
All Filings in WGS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,477,943 | 459,015 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||